Rovalpituzumab Biosimilar (DLL3 Reference Antibody)
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3) . Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC) .
Product Specifications
Target
Rovalpituzumab Biosimilar (Anti-DLL3 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Stem Cell & Developmental Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rabbit Monoclonal ETHE1 Antibody (001) [Biotin]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
sc-348659 250 mg
4-[ (6-amino-2,4-dioxo-1-propyl-1,2,3,4-tetrahydropyrimidin-5-yl) (butyl) amino]-4-oxobutanoic acid
Sign In for Pricing
View Details MBS6233983-01 0.1 mL
MTMR9 (Myotubularin-related Protein 9, C8orf9, MTMR8, C8orf9, DKFZp434K171, MGC126672) (MaxLight 750)
Sign In for Pricing
View Details MBS6233983-02 5x 0.1 mL
MTMR9 (Myotubularin-related Protein 9, C8orf9, MTMR8, C8orf9, DKFZp434K171, MGC126672) (MaxLight 750)
Sign In for Pricing
View Details 
